Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bacterial vaginosis.

J D Sobel1

  • 1Division of Infectious Diseases, Wayne University School of Medicine, Harper Hospital, Detroit, Michigan.

British Journal of Clinical Practice. Supplement
|September 1, 1990
PubMed
Summary
This summary is machine-generated.

Bacterial vaginosis (BV) is a common vaginal infection caused by an overgrowth of anaerobic bacteria. Early BV recurrences are typically relapses, not reinfections, and are not linked to antimicrobial resistance.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Automated microscopy and pH test for diagnosis of vaginitis - the end of empiricism?

NPJ digital medicine·2023
Same author

Resistance to Fluconazole of Candida albicans in Vaginal Isolates: a 10-Year Study in a Clinical Referral Center.

Antimicrobial agents and chemotherapy·2023
Same author

Efficacy and safety of oral ibrexafungerp for the treatment of acute vulvovaginal candidiasis: a global phase 3, randomised, placebo-controlled superiority study (VANISH 306).

BJOG : an international journal of obstetrics and gynaecology·2021
Same author

Recurrent bacterial vaginosis, relapse or reinfection: the role of sexual transmission.

BJOG : an international journal of obstetrics and gynaecology·2020
Same author

Vulvovaginitis Caused by Candida Species Following Antibiotic Exposure.

Current infectious disease reports·2019
Same author

Candida parapsilosis Vaginal Infection-a New Site of Azole Drug Resistance.

Current infectious disease reports·2018
Same journal

Treatment of dyslipidaemias with fluvastatin.

British journal of clinical practice. Supplement·2009
Same journal

Lipoprotein(a) as a marker for coronary heart disease.

British journal of clinical practice. Supplement·2009
Same journal

Fluvastatin for the prevention of restenosis after coronary balloon angioplasty: angiographic and methodological background of the fluvastatin angioplasty restenosis trial.

British journal of clinical practice. Supplement·2009
Same journal

Risk factor management: the cardiologist's perspective.

British journal of clinical practice. Supplement·2009
Same journal

Fluvastatin in combination with other lipid-lowering agents.

British journal of clinical practice. Supplement·2009
Same journal

The patient at risk: who should we be treating?

British journal of clinical practice. Supplement·2009
See all related articles

Area of Science:

  • Gynecology
  • Microbiology
  • Infectious Diseases

Background:

  • Bacterial vaginosis (BV) is the most prevalent cause of vaginitis in Western countries.
  • It involves a significant disruption of vaginal microbiota, characterized by an overgrowth of anaerobic bacteria and a decrease in Lactobacillus species.
  • Key diagnostic markers include clue cells, elevated vaginal pH, and excessive polyamine production.

Purpose of the Study:

  • To investigate the underlying causes of recurrent bacterial vaginosis.
  • To determine whether early recurrences are due to relapse or reinfection.
  • To assess the role of antimicrobial resistance in treatment failures.

Main Methods:

  • The study analyzed clinical data and microbiological findings from patients experiencing recurrent bacterial vaginosis.

Related Experiment Videos

  • Specific focus was placed on identifying the microbial composition during initial diagnosis and subsequent episodes.
  • Antimicrobial susceptibility testing was performed to evaluate resistance patterns.

    • Main Results:

    • High levels of anaerobic bacteria such as non-fragilis Bacteroides, peptostreptococci, Gardnerella vaginalis, and Mobiluncus species were observed.
    • A corresponding decrease in protective Lactobacillus species was noted.
    • New data indicate that early recurrences of BV are primarily due to relapse rather than reinfection.

    Conclusions:

    • The findings suggest that early recurrent bacterial vaginosis stems from a relapse of the initial condition.
    • There is currently no evidence to support antimicrobial resistance as a cause for these relapses.
    • Further research is needed to understand the pathogenesis and develop effective treatments for recurrent BV, especially in pregnant women.